India claims 40% drop in fake drugs despite uptick in testing
The number of fake or adulterated drugs found in India fell 40 per cent from 2008 to 2010 despite an uptick in testing, government data claims.
The number of fake or adulterated drugs found in India fell 40 per cent from 2008 to 2010 despite an uptick in testing, government data claims.
The EMA wants greater engagement from the drug industry to help it modernise regulation and join the "unconnected boxes" that separate stakeholders.
Affymetrix will distribute a mircoarray developed by Almac for personalised medicine development applications under an exclusive global distribution deal.
The FDA will assess industry responses to drug cargo thefts as part of its fight back against crimes in the pharmaceutical supply chain.
in-PharmaTechnologist presents its weekly round-up of the latest appointments within the pharmaceutical industry including news from Raptor, Cangene and Merck & Co.